http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2480690-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72b5c05458a2a1ff279681f3232ef626 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2006-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_772e20f7846f3b57a3a16aab0d141125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7fe47b73ca1f4646dc8f69a7b66fc1e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c16c8906fbb4e0d854a32ade10d8ae12 |
| publicationDate | 2014-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2480690-T3 |
| titleOfInvention | In vitro procedure for the prognosis of the progression of a cancer and of the result in a patient and means to carry out said procedure |
| abstract | An in vitro procedure for the prognosis of patients for the progression of a cancer, said procedure comprising the following steps: a) quantifying, in a tumor tissue sample of said patient, one or more biological markers indicative of the state of the adaptive immune response of said patient against cancer; and b) comparing the value obtained in step a) for said one or more biological markers with a predetermined reference value for the same biological markers; predetermined reference value that correlates with a specific prognosis of said cancer progression, wherein said one or more biological markers comprise integrin alpha E (ITGAE). |
| priorityDate | 2005-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.